FGD3 Boosts Breast Cancer Treatment – Chemotherapy & Immunotherapy
- * Title: FGD3 mediates lytic cell death, enhancing efficacy and immunogenicity of chemotherapy agents in breast cancer * Journal: Journal of Experimental & Clinical Cancer Research *...
- * Provided by: University of Illinois at Urbana-Champaign * University Website: http://illinois.edu/
- * Title: Cellular protein FGD3 boosts breast cancer chemotherapy and immunotherapy, study finds * Date: November 12, 2025 * Retrieved Date: november 12, 2025 (likely the date...
Here’s a breakdown of the information provided in the text:
Research Article:
* Title: FGD3 mediates lytic cell death, enhancing efficacy and immunogenicity of chemotherapy agents in breast cancer
* Journal: Journal of Experimental & Clinical Cancer Research
* Publication Year: 2025
* DOI: 10.1186/s13046-025-03559-5
* key Finding: The cellular protein FGD3 enhances the effectiveness of both chemotherapy and immunotherapy in treating breast cancer.
Source:
* Provided by: University of Illinois at Urbana-Champaign
* University Website: http://illinois.edu/
Citation (for print):
* Title: Cellular protein FGD3 boosts breast cancer chemotherapy and immunotherapy, study finds
* Date: November 12, 2025
* Retrieved Date: november 12, 2025 (likely the date of publication/access)